IL123322A0 - Tetrahydroquinolines their preparation and pharmaceutical compositions containing them - Google Patents

Tetrahydroquinolines their preparation and pharmaceutical compositions containing them

Info

Publication number: IL123322A0
Authority: IL; Israel
Prior art keywords: tetrahydroquinolines; preparation; pharmaceutical compositions; compositions containing; pharmaceutical
Prior art date: 1995-09-29

Application number

IL12332296A

Other languages

English (en)

Original Assignee

Glaxo Wellcome Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-29

Filing date

1996-09-26

Publication date

1998-09-24

1995-09-29 Priority claimed from GBGB9519893.3A external-priority patent/GB9519893D0/en

1996-08-17 Priority claimed from GBGB9617306.7A external-priority patent/GB9617306D0/en

1996-09-26 Application filed by Glaxo Wellcome Spa filed Critical Glaxo Wellcome Spa

1998-09-24 Publication of IL123322A0 publication Critical patent/IL123322A0/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
150000003530 tetrahydroquinolines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Virology (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Heart & Thoracic Surgery (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Addiction (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

IL12332296A 1995-09-29 1996-09-26 Tetrahydroquinolines their preparation and pharmaceutical compositions containing them IL123322A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9519893.3A GB9519893D0 (en)	1995-09-29	1995-09-29	Heterocyclic compounds
GBGB9617306.7A GB9617306D0 (en)	1996-08-17	1996-08-17	Heterocyclic compounds
PCT/EP1996/004206 WO1997012870A1 (en)	1995-09-29	1996-09-26	Tetrahydroquinolines as nmda antagonists

Publications (1)

Publication Number	Publication Date
IL123322A0 true IL123322A0 (en)	1998-09-24

Family

ID=26307841

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12332296A IL123322A0 (en)	1995-09-29	1996-09-26	Tetrahydroquinolines their preparation and pharmaceutical compositions containing them

Country Status (28)

Country	Link
US (1)	US5977136A (de)
EP (1)	EP0854867B1 (de)
JP (1)	JP4108123B2 (de)
KR (1)	KR100464895B1 (de)
CN (1)	CN1130346C (de)
AP (1)	AP876A (de)
AR (1)	AR005233A1 (de)
AT (1)	ATE221520T1 (de)
AU (1)	AU708148B2 (de)
BR (1)	BR9610733A (de)
CA (1)	CA2232509A1 (de)
CZ (1)	CZ292379B6 (de)
DE (1)	DE69622731T2 (de)
DK (1)	DK0854867T3 (de)
EA (1)	EA000875B1 (de)
ES (1)	ES2180799T3 (de)
HU (1)	HUP9900040A3 (de)
IL (1)	IL123322A0 (de)
IS (1)	IS4677A (de)
MX (1)	MX9801967A (de)
NO (1)	NO310355B1 (de)
NZ (1)	NZ319596A (de)
PL (1)	PL186781B1 (de)
PT (1)	PT854867E (de)
SI (1)	SI0854867T1 (de)
TR (1)	TR199800531T1 (de)
TW (1)	TW460465B (de)
WO (1)	WO1997012870A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9617305D0 (en) *	1996-08-17	1996-09-25	Glaxo Wellcome Spa	Heterocyclic compounds
GB9706294D0 (en) *	1997-03-26	1997-05-14	Glaxo Wellcome Spa	Heterocyclic compound
MY125037A (en)	1998-06-10	2006-07-31	Glaxo Wellcome Spa	1,2,3,4 tetrahydroquinoline derivatives
TW555757B (en) *	1998-07-31	2003-10-01	Akzo Nobel Nv	Aminomethylcarboxylic acid derivatives
AU5194999A (en) *	1998-08-07	2000-02-28	Takeda Chemical Industries Ltd.	Benzothiepin derivatives, process for the preparation of the same and uses thereof
GB9929037D0 (en) *	1999-12-08	2000-02-02	Glaxo Wellcome Spa	Heterocyclic derivatives
NZ533566A (en) *	2001-12-28	2007-03-30	Acadia Pharm Inc	Tetrahydroquinoline analogues as muscarinic agonists
DE10236910A1 (de) *	2002-08-12	2004-03-11	Grünenthal GmbH	Substituierte 1,2,3,4-Tetrahydrochinolinderivate
JP4754566B2 (ja)	2005-07-22	2011-08-24	持田製薬株式会社	新規なヘテロシクリデンアセトアミド誘導体
RU2451014C2 (ru) *	2005-07-22	2012-05-20	Мотида Фармасьютикал Ко., Лтд.	Новое производное гетероциклиден ацетамида
EP2268644B1 (de)	2008-03-05	2011-08-17	Boehringer Ingelheim International GmbH	Tricyclische pyridinderivate, solche verbindungen enthaltende medikamente, ihre verwendung und verfahren zu ihrer herstellung
EP2286808A1 (de) *	2009-08-18	2011-02-23	Rheinische Friedrich-Wilhelms Universität	Cytohesininhibitoren
AU2011216950A1 (en)	2010-02-16	2012-08-23	Pfizer Inc.	(R)-4-((4-((4-(tetrahydrofuran-3-yloxy) benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol, a partial agonist of 5-HT4 receptors
MX2012009149A (es)	2010-02-19	2012-09-28	Boehringer Ingelheim Int	Derivados de piridina triciclicos, medicamentos que contienen tales compuestos, su uso y proceso para su preparacion.
US9150583B2 (en)	2011-08-17	2015-10-06	Boehringer Ingelheim International Gmbh	Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
WO2016114655A1 (en) *	2015-01-12	2016-07-21	Ry Pharma B.V.	Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation
WO2017065602A1 (en) *	2015-10-13	2017-04-20	Ry Pharma B.V.	Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE147732T1 (de) *	1989-03-08	1997-02-15	Merck Sharp & Dohme	Tetrahydroquinolin-derivate, verwendbar bei neurodegenerativen krankheiten

1996
- 1996-09-26 AT AT96933399T patent/ATE221520T1/de not_active IP Right Cessation
- 1996-09-26 DE DE69622731T patent/DE69622731T2/de not_active Expired - Lifetime
- 1996-09-26 WO PCT/EP1996/004206 patent/WO1997012870A1/en not_active Ceased
- 1996-09-26 SI SI9630523T patent/SI0854867T1/xx unknown
- 1996-09-26 EA EA199800230A patent/EA000875B1/ru not_active IP Right Cessation
- 1996-09-26 DK DK96933399T patent/DK0854867T3/da active
- 1996-09-26 TR TR1998/00531T patent/TR199800531T1/xx unknown
- 1996-09-26 IL IL12332296A patent/IL123322A0/xx not_active IP Right Cessation
- 1996-09-26 CN CN96198560A patent/CN1130346C/zh not_active Expired - Fee Related
- 1996-09-26 JP JP51394797A patent/JP4108123B2/ja not_active Expired - Fee Related
- 1996-09-26 EP EP96933399A patent/EP0854867B1/de not_active Expired - Lifetime
- 1996-09-26 KR KR10-1998-0702321A patent/KR100464895B1/ko not_active Expired - Fee Related
- 1996-09-26 AU AU72148/96A patent/AU708148B2/en not_active Ceased
- 1996-09-26 US US09/029,860 patent/US5977136A/en not_active Expired - Fee Related
- 1996-09-26 PL PL96325966A patent/PL186781B1/pl not_active IP Right Cessation
- 1996-09-26 CA CA002232509A patent/CA2232509A1/en not_active Abandoned
- 1996-09-26 PT PT96933399T patent/PT854867E/pt unknown
- 1996-09-26 CZ CZ1998940A patent/CZ292379B6/cs not_active IP Right Cessation
- 1996-09-26 AP APAP/P/1998/001212A patent/AP876A/en active
- 1996-09-26 ES ES96933399T patent/ES2180799T3/es not_active Expired - Lifetime
- 1996-09-26 HU HU9900040A patent/HUP9900040A3/hu unknown
- 1996-09-26 BR BR9610733A patent/BR9610733A/pt not_active IP Right Cessation
- 1996-09-26 NZ NZ319596A patent/NZ319596A/en not_active IP Right Cessation
- 1996-09-30 AR ARP960104543A patent/AR005233A1/es active IP Right Grant
- 1996-10-04 TW TW085112168A patent/TW460465B/zh not_active IP Right Cessation
1998
- 1998-02-27 IS IS4677A patent/IS4677A/is unknown
- 1998-03-12 MX MX9801967A patent/MX9801967A/es not_active IP Right Cessation
- 1998-03-27 NO NO19981396A patent/NO310355B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0854867A1 (de)	1998-07-29
NO310355B1 (no)	2001-06-25
HK1009133A1 (en)	1999-05-28
HUP9900040A2 (hu)	1999-04-28
AU708148B2 (en)	1999-07-29
ATE221520T1 (de)	2002-08-15
NO981396L (no)	1998-05-27
DE69622731D1 (de)	2002-09-05
CN1202887A (zh)	1998-12-23
PL325966A1 (en)	1998-08-17
JPH11512728A (ja)	1999-11-02
CN1130346C (zh)	2003-12-10
EP0854867B1 (de)	2002-07-31
ES2180799T3 (es)	2003-02-16
BR9610733A (pt)	1999-07-13
DK0854867T3 (da)	2002-12-02
SI0854867T1 (en)	2003-02-28
DE69622731T2 (de)	2003-02-20
CA2232509A1 (en)	1997-04-10
TR199800531T1 (xx)	1998-06-22
US5977136A (en)	1999-11-02
TW460465B (en)	2001-10-21
EA000875B1 (ru)	2000-06-26
AU7214896A (en)	1997-04-28
CZ292379B6 (cs)	2003-09-17
PL186781B1 (pl)	2004-02-27
AR005233A1 (es)	1999-04-28
KR19990063850A (ko)	1999-07-26
AP876A (en)	2000-09-27
KR100464895B1 (ko)	2005-05-16
PT854867E (pt)	2002-12-31
AP9801212A0 (en)	1998-03-31
MX9801967A (es)	1998-08-30
JP4108123B2 (ja)	2008-06-25
HUP9900040A3 (en)	2001-01-29
NZ319596A (en)	1999-09-29
EA199800230A1 (ru)	1998-10-29
WO1997012870A1 (en)	1997-04-10
NO981396D0 (no)	1998-03-27
CZ94098A3 (cs)	1998-07-15
IS4677A (is)	1998-02-27

Legal Events

Date	Code	Title
2001-06-14	KB	Patent renewed
2002-11-10	KB	Patent renewed
2006-10-30	KB	Patent renewed
2011-06-30	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
IL117860A0 (en)	1996-08-04	Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL121236A0 (en)	1998-01-04	Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL122293A0 (en)	1998-04-05	Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL117636A0 (en)	1996-07-23	Taxoids their preparation and pharmaceutical compositions containing them
ZA9610737B (en)	1997-06-27	Taxoids their preparation and pharmaceutical compositions containing them
IL116851A (en)	2000-06-01	3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
IL111518A (en)	1999-06-20	Isoquinolines their preparation and pharmaceutical compositions containing them
IL119995A0 (en)	1997-04-15	Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL122618A0 (en)	1998-08-16	Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them
IL121235A0 (en)	1998-01-04	Bicyclic-fused pyridines their preparation and pharmaceutical compositions containing them
IL115905A0 (en)	1996-01-31	Sordarin derivatives their preparation and pharmaceutical compositions containing them
IL119559A0 (en)	1997-02-18	Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
IL119316A0 (en)	1996-12-05	Hydroxypyridinones their preparation and pharmaceutical compositions containing them
IL117349A0 (en)	1996-07-23	N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
IL125710A0 (en)	1999-04-11	Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
IL117554A0 (en)	1996-07-23	Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL112889A (en)	1999-06-20	Beta-lactams their preparation and pharmaceutical compositions containing them
IL117815A0 (en)	1996-08-04	Ascomycins their preparation and pharmaceutical compositions containing them
IL117878A (en)	2001-03-19	Taxoids their preparation and pharmaceutical compositions containing them
ZA967800B (en)	1997-04-03	Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
IL116480A0 (en)	1996-03-31	Acetic acid deriratives their preparation and pharmaceutical compositions containing them
ZA962633B (en)	1996-10-07	Taxoids their preparation and pharmaceutical compositions containing them
IL118054A0 (en)	1996-08-04	(Het) aryloxy-,(-thio- and -amino-)-crotonates their preparation and pharmaceutical compositions containing them
IL118672A (en)	2000-10-31	Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en)	1997-01-10	Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them